Perfluorohexyloctane and lotilaner ophthalmic solution, 2 ocular surface disease drugs, have changed the DED and DB treatment paradigms.
The global ophthalmic sprays market, valued at USD 343 million in 2023, is projected to experience exponential growth, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback